These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4601078)

  • 41. [Temporary blindness as a symptoms of circulatory disorder].
    Makabe R
    Med Klin; 1981 Oct; 76(21):597-9. PubMed ID: 7300786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
    Gent M; Barnett HJ; Sackett DL; Taylor DW
    Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
    Weiss HJ
    Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
    Einecke D
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495
    [No Abstract]   [Full Text] [Related]  

  • 46. Antiplatelet drugs after myocardial infarction.
    Med Lett Drugs Ther; 1980 Mar; 22(6):25-6. PubMed ID: 7360108
    [No Abstract]   [Full Text] [Related]  

  • 47. The anturane reinfarction trial.
    Sherry S
    Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevention of cerebral vasospasm with tissue plasminogen activator].
    Yamada K; Ohta T
    No To Shinkei; 1993 Sep; 45(9):809-17. PubMed ID: 8217407
    [No Abstract]   [Full Text] [Related]  

  • 49. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 50. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
    Diener HC
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366496
    [No Abstract]   [Full Text] [Related]  

  • 51. [Etiological studies on 17 cases of retinal artery occlusion and 16 cases of amaurosis fugax].
    Hashimoto Y; Terasaki T; Hara Y; Furuyoshi N; Uchino M
    Rinsho Shinkeigaku; 1998 Mar; 38(3):219-23. PubMed ID: 9711117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Present status of the therapy of acute cerebral transient ischemic attacks].
    Saavedra JC; Vergara F
    Rev Med Chil; 1983 Jan; 111(1):55-60. PubMed ID: 6648080
    [No Abstract]   [Full Text] [Related]  

  • 53. A stochastic model for the occurrence of transient ischemic attacks.
    Dunn JK; Hardy RJ
    Biometrics; 1980 Mar; 36(1):91-103. PubMed ID: 6989410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient cerebral ischaemic attacks--management and prognosis.
    Roden S; Low-Beer T; Carmalt M; Cockel R; Green I
    Postgrad Med J; 1981 May; 57(667):275-8. PubMed ID: 7029501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program].
    Fontanilles F
    Wien Med Wochenschr Suppl; 1980; 61():23-4. PubMed ID: 6930767
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical Grand Rounds: extracranial carotid artery disease.
    Cain TD; Wood JS; Beard OW
    J Ark Med Soc; 1980 Jan; 76(1):323-30. PubMed ID: 6444401
    [No Abstract]   [Full Text] [Related]  

  • 57. Amaurosis fugax.
    Pryse-Phillips W
    Br Med J (Clin Res Ed); 1982 Oct; 285(6348):1066-8. PubMed ID: 6812749
    [No Abstract]   [Full Text] [Related]  

  • 58. A controlled trial of the effect of calmic 131A in the treatment of transient cerebral ischaemic attacks.
    Millar JH; Wilson HE
    J Atheroscler Res; 1968; 8(1):192-5. PubMed ID: 4868111
    [No Abstract]   [Full Text] [Related]  

  • 59. Amaurosis fugax: controversies in management.
    Beck RW
    Int Ophthalmol Clin; 1986; 26(4):277-84. PubMed ID: 3804631
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effects of streptokinase on the formation of thrombocyte aggregates following complete cerebral ischemia].
    Hirsch H; Beneicke U; Künzel HP
    Blut; 1965 Nov; 12(2):78-83. PubMed ID: 5853845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.